Matches in SemOpenAlex for { <https://semopenalex.org/work/W3207337699> ?p ?o ?g. }
- W3207337699 endingPage "1203" @default.
- W3207337699 startingPage "1172" @default.
- W3207337699 abstract "Brain cancer is a formidable challenge for drug development, and drugs derived from many cutting-edge technologies are being tested in clinical trials. We manually characterized 981 clinical trials on brain tumors that were registered in ClinicalTrials.gov from 2010 to 2020. We identified 582 unique therapeutic entities targeting 581 unique drug targets and 557 unique treatment combinations involving drugs. We performed the classification of both the drugs and drug targets based on pharmacological and structural classifications. Our analysis demonstrates a large diversity of agents and targets. Currently, we identified 32 different pharmacological directions for therapies that are based on 42 structural classes of agents. Our analysis shows that kinase inhibitors, chemotherapeutic agents, and cancer vaccines are the three most common classes of agents identified in trials. Agents in clinical trials demonstrated uneven distribution in combination approaches; chemotherapy agents, proteasome inhibitors, and immune modulators frequently appeared in combinations, whereas kinase inhibitors, modified immune effector cells did not as was shown by combination networks and descriptive statistics. This analysis provides an extensive overview of the drug discovery field in brain cancer, shifts that have been happening in recent years, and challenges that are likely to come. SIGNIFICANCE STATEMENT: This review provides comprehensive quantitative analysis and discussion of the brain cancer drug discovery field, including classification of drug, targets, and therapies." @default.
- W3207337699 created "2021-10-25" @default.
- W3207337699 creator A5005641756 @default.
- W3207337699 creator A5009902299 @default.
- W3207337699 creator A5012846308 @default.
- W3207337699 creator A5019294144 @default.
- W3207337699 creator A5036836779 @default.
- W3207337699 creator A5042260375 @default.
- W3207337699 creator A5076369391 @default.
- W3207337699 creator A5085396890 @default.
- W3207337699 creator A5085987018 @default.
- W3207337699 creator A5088553202 @default.
- W3207337699 date "2021-10-01" @default.
- W3207337699 modified "2023-09-30" @default.
- W3207337699 title "Brain Cancer Drug Discovery: Clinical Trials, Drug Classes, Targets, and Combinatorial Therapies" @default.
- W3207337699 cites W1544009106 @default.
- W3207337699 cites W187893052 @default.
- W3207337699 cites W1968045648 @default.
- W3207337699 cites W1976295398 @default.
- W3207337699 cites W1978880915 @default.
- W3207337699 cites W1983277414 @default.
- W3207337699 cites W1986034385 @default.
- W3207337699 cites W1988474688 @default.
- W3207337699 cites W1993543117 @default.
- W3207337699 cites W1997288028 @default.
- W3207337699 cites W1998196049 @default.
- W3207337699 cites W2008238182 @default.
- W3207337699 cites W2010573862 @default.
- W3207337699 cites W2011219467 @default.
- W3207337699 cites W2014014132 @default.
- W3207337699 cites W2018918678 @default.
- W3207337699 cites W2022953507 @default.
- W3207337699 cites W2029335938 @default.
- W3207337699 cites W2031441006 @default.
- W3207337699 cites W2037248548 @default.
- W3207337699 cites W2038385234 @default.
- W3207337699 cites W2038900628 @default.
- W3207337699 cites W2038985537 @default.
- W3207337699 cites W2039075677 @default.
- W3207337699 cites W2039109621 @default.
- W3207337699 cites W2040751953 @default.
- W3207337699 cites W2047480689 @default.
- W3207337699 cites W2059860479 @default.
- W3207337699 cites W2063026953 @default.
- W3207337699 cites W2063463358 @default.
- W3207337699 cites W2064578746 @default.
- W3207337699 cites W2076708252 @default.
- W3207337699 cites W2084170466 @default.
- W3207337699 cites W2093959377 @default.
- W3207337699 cites W2111742915 @default.
- W3207337699 cites W2119754956 @default.
- W3207337699 cites W2121725913 @default.
- W3207337699 cites W2125377515 @default.
- W3207337699 cites W2127289529 @default.
- W3207337699 cites W2132173287 @default.
- W3207337699 cites W2143078369 @default.
- W3207337699 cites W2148401772 @default.
- W3207337699 cites W2159059319 @default.
- W3207337699 cites W2163838780 @default.
- W3207337699 cites W2164306001 @default.
- W3207337699 cites W2164475208 @default.
- W3207337699 cites W2165560566 @default.
- W3207337699 cites W2167865938 @default.
- W3207337699 cites W2169303586 @default.
- W3207337699 cites W2209812019 @default.
- W3207337699 cites W2253992243 @default.
- W3207337699 cites W2302851559 @default.
- W3207337699 cites W2313965855 @default.
- W3207337699 cites W2331464949 @default.
- W3207337699 cites W2342423058 @default.
- W3207337699 cites W2346727850 @default.
- W3207337699 cites W2497822529 @default.
- W3207337699 cites W2528259158 @default.
- W3207337699 cites W2558217333 @default.
- W3207337699 cites W2561499686 @default.
- W3207337699 cites W2567664749 @default.
- W3207337699 cites W2580786621 @default.
- W3207337699 cites W2586159641 @default.
- W3207337699 cites W2589879570 @default.
- W3207337699 cites W2593529561 @default.
- W3207337699 cites W2597045666 @default.
- W3207337699 cites W2597795073 @default.
- W3207337699 cites W2609266387 @default.
- W3207337699 cites W2619886251 @default.
- W3207337699 cites W2622931261 @default.
- W3207337699 cites W2624407975 @default.
- W3207337699 cites W2749747068 @default.
- W3207337699 cites W2753630019 @default.
- W3207337699 cites W2759239761 @default.
- W3207337699 cites W2761586559 @default.
- W3207337699 cites W2765153686 @default.
- W3207337699 cites W2765322467 @default.
- W3207337699 cites W2767198352 @default.
- W3207337699 cites W2768347409 @default.
- W3207337699 cites W2777646885 @default.
- W3207337699 cites W2779743226 @default.
- W3207337699 cites W2783146090 @default.
- W3207337699 cites W2792103835 @default.